[Bronchial asthma in children. Furthering compliance].
Success in treating and managing bronchial asthma in children and adolescents is known to rely on active cooperation on behalf of both the patients and their parents. Compliance in terms of pharmaceutical or behavioural intervention is often insufficient to prevent further aggravation and exacerbation. Specific measures for enhancing therapy compliance have been well received in the German Health Care System, and research results indicate their effectiveness in reducing health care utilization and in improving quality of life. Studies that would ascribe such effects to regular medication intake or reduced exposure to allergic elicitors, however, are still lacking.
Petermann
Franz
F
Universität Bremen, BRD. fpeterm@uni-bremen.de
Schauerte
G
G
D000293:Adolescent; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control / Q000523:psychology; D017028:Caregivers / Q000193:education / Q000523:psychology; D002648:Child; D002675:Child, Preschool; D005858:Germany; D006801:Humans; D007223:Infant; D010349:Patient Compliance / Q000523:psychology*; D010353:Patient Education as Topic; D011368:Professional-Family Relations; D012307:Risk Factors; D012648:Self Care
D018927:Anti-Asthmatic Agents